PFA Visualization on EnSite™ X EP System Supported by Abbott's Expert Clinical Specialists
The right system for your procedures is the one that allows you to treat AFib your way for optimal outcomes, safety and efficiency.
Abbott gives you more opportunities to choose the course of treatment and workflow that’s right for your patients, because #MappingMatters. EnSite™ X EP System - THE INDUSTRY’S ONLY OPEN ARCHITECTURE DESIGN - is the only system to offer a comprehensive solution for RF and PFA procedures – from mapping to outcomes.
Map to Reduce Radiation and Elevate Safety
Every patient deserves 3D mapping to increase navigation accuracy, reduce radiation risk, optimize workflow, and potentially improve outcomes in mapping PVI and beyond.
RADIATION RISK DURING EP PROCEDURES
NEARLY ZERO RADIATION WITH ENSITE™ X EP SYSTEM
EnSite™ X EP System stands alone as the only open architecture mapping system capable of driving fluoroscopy exposure to nearly zero1 with its combination of 3D mapping, PFA visualization and lowest radiation exposure ablation times3.
PFA visualization with EnSite™ X EP System may reduce fluoroscopy times during PFA procedures.
EnSite™ X EP System with TactiFlex™ Ablation Catheter, Sensor Enabled™ has the lowest radiation3 exposure time compared to other technologies in the market, proven by the TactiFlex IDE trial.
Improve Procedural Success Rates For All AF Types. Map Beyond PVI.
EnSite™ X EP System provides the mapping flexibility, detail and real-time technology vital for low-voltage area ablation procedures. Map beyond PVI to identify, target and ablate cardiac tissue with specificity for acute and long-term outcomes. Patients undergoing 3D mapping-guided low-voltage area are experiencing greater freedom from paroxysmal and persistent AF.
SIGNIFICANTLY REDUCE ATRIAL TACHYARRHYTHMIA RECURRENCE WITH 3D MAPPING-GUIDED LOW-VOLTAGE AREA THERAPY9
Fewer atrial tachyarrhythmia recurrences9
Lower number of redo ablation procedures9
Similar results for all AF types – paroxysmal, persistent and long-standing persistent AF9
IMPROVE LONG-TERM OUTCOMES IN OLDER PATIENTS WITH PAROXYSMAL AF3
39% lower rate of recurrence for patients with persistent AF undergoing PVI with substrate modification vs PVI only (35% vs. 50%)10
2-3 year improved outcomes; differentiation in patient populations noted at 1 year3
REDUCE ATRIAL ARRHYTHMIA RECURRENCE RATES AND AVOID OVERABLATION10
15% lower rate of recurrence for patients with persistent AF undergoing PVI with substrate modification vs PVI only (35% vs. 50%)10
TAILOR ABLATION STRATEGIES TO PROMOTE BETTER ACUTE AND LONG-TERM CLINICAL OUTCOMES FOR PERSISTENT AF11
PATIENTS UNDERGOING CIRCUMFERENTIAL PV ABLATION11:
50% Improved acute intraprocedural arrhythmia termination11
13% Higher procedural success rates11
CREATE EFFICIENCIES. MAP TO OPTIMIZE WORKFLOW.
One System Solution: the only open architecture design that gives you full flexibility to treat AFib your way.
*The EnSite™ X EP System has an open architecture which is capable of providing impedance based visualization for any catheter, which can be connected the the system via direct connection or with pins using the catheter input module.
REFERENCES:
- Fiorenzo Gaita, Peter G. Guerra. Alberto Battaglia, Matteo Anselmino (2016). The Dream of near-zero X-Rays ablation comes True. European Heart Journal, Volume 37, Issue 36, 21 September 2016.
- Nair, D., Martinek, M., Colley, B. J., Sundaram, S., Hariharan, R., Morales, G., ... & Lo, M. (2023). Safety and effectiveness of the first contact force ablation catheter with a flexible tip. Heart Rhythm O2, 4(12), 784-793.
- Chen, H. et al. (2023). Circumferential pulmonary vein isolation with vs without additional low-voltage-area ablation in older patients with paroxysmal atrial fibrillation. JAMA Cardiology, 8(8), 765. https://doi.org/10.1001/jamacardio.2023.1749.
- Jose Osorio, Gustavo Morales, Michael Raiman (2023) High Efficiency Workflow During Atrial Fibrillation Ablation: Protocol and Experience with EnSite X Mapping System, July 2023, Vol.16 Issue 5.
- Osorio, J., Hussein, A. A., Delaughter, M. C., Monir, G., Natale, A., Dukkipati, S., ... & Q-FFICIENCY Trial Investigators. (2023). Very high-power short-duration, temperature-controlled radiofrequency ablation in paroxysmal atrial fibrillation: the prospective multicenter Q-FFICIENCY trial. Clinical Electrophysiology, 9(4), 468-480.
- Mohit K. Turagam , MD; Petr Neuzil , MD PhD; Boris Schmidt , MD; Tobias Reichlin , MD; Kars Neven, MD; Andreas Metzner, MD; Jim Hansen, MD; Yuri Blaauw, MD…… Philippe Maury,MD (2023) Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry. Circulation. 2023;148:35–46. DOI: 10.1161/CIRCULATIONAHA.123.064959.
- Reddy, V. Y., Gerstenfeld, E. P., Natale, A., Whang, W., Cuoco, F. A., Patel, C., ... & Mansour, M. (2023). Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. New England Journal of Medicine, 389(18), 1660-1671.
- Verma, A., Haines, D. E., Boersma, L. V., Sood, N., Natale, A., Marchlinski, F. E., ... & PULSED AF Investigators. (2023). Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation,147(19), 1422-1432.
- Rivera, A. et al. (2024). Adjunctive Low-voltage area ablation for patients with atrial fibrillation: An updated meta-analysis of Randomized Controlled Trials. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16290.
- Huo, Y. et al. (2022). Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation. NEJM Evidence, 1(11). https://doi.org/10.1056/evidoa2200141.
- Pappone, C. et al. (2018). Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique. Circulation: Arrhythmia and Electrophysiology, 11(3). https://doi.org/10.1161/circep.117.005904.
MAT-2405176 v4.0
Stay Connected